Article
Upregulation of N-acetylaspartic acid resulting nitric oxide toxicity induces aspartoacylase mutations and protein interaction to cause pathophysiology seen in Canavan disease.
Medical hypotheses - 1 Dec 2010
Surendran Sankar
Abstract excerpt
Aspartoacylase (ASPA) converts N-acetylaspartic acid into aspartate and acetate. In Canavan disease (CD), N-acetylaspartic acid (NAA) is found to be increased and over 65 mutations including IVS4+1 G → T, deletion of introns and exons have been reported in the ASPA gene. These changes lead to sev...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
